Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Julphar for the commercialization of its V-Go wearable insulin delivery device in the member states of the Gulf Cooperation Council.
Valeritas has deals in place to bring its V-Go device to 14 countries and territories, including Australia, Slovenia and Puerto Rico. The company is also working to win regulatory approval for the product in China.
Get the full story at our sister site, Drug Delivery Business News.
The post Valeritas inks Middle East distro deal for V-Go insulin delivery device appeared first on MassDevice.
from MassDevice https://ift.tt/2PTbasq
Cap comentari:
Publica un comentari a l'entrada